Back to top
more

Doximity (DOCS)

(Delayed Data from NYSE)

$75.12 USD

75.12
1,364,908

+0.72 (0.97%)

Updated Sep 29, 2025 04:00 PM ET

After-Market: $75.14 +0.02 (0.03%) 7:52 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (63 out of 245)

Industry: Medical Info Systems

Zacks News

Zacks Equity Research

The Zacks Analyst Blog Highlights McKesson, Doximity and Veracyte

McKesson, Doximity and Veracyte are included in this Analyst Blog.

Kaibalya Pravo Dey headshot

Prescription for Profits: 3 Must-Buy Healthcare Stocks Before 2025

The healthcare sector is undergoing significant changes, with technology, innovation and a patient-centric approach as the cornerstones of its growth.

Zacks Equity Research

The Zacks Analyst Blog Highlights Garmin, Sprouts Farmers Market, Doximity, Peloton Interactive and Planet Fitness

Garmin, Sprouts Farmers Market, Doximity, Peloton Interactive and Planet Fitness are included in this Analyst Blog.

Nalak Das headshot

Buy 5 High-Flying Health & Fitness Stocks of 2024 With More Upside

Five Health & Fitness stocks have strong growth potential for 2025. These are GRMN, SFM, DOCS, PLNT and PTON.

Zacks Equity Research

Are Options Traders Betting on a Big Move in Doximity (DOCS) Stock?

Investors need to pay close attention to Doximity (DOCS) stock based on the movements in the options market lately.

Zacks Equity Research

Are Medical Stocks Lagging Doximity (DOCS) This Year?

Here is how Doximity (DOCS) and AxoGen (AXGN) have performed compared to their sector so far this year.

Zacks Equity Research

Zacks.com featured highlights Amazon, Maplebear, Exelixis and Doximity

Amazon, Maplebear, Exelixis and Doximity have been highlighted in this Screen of The Week article.

Zacks Equity Research

Zacks.com featured highlights Doximity, Impinj and Innodata

Doximity, Impinj and Innodata have been highlighted in this Screen of The Week article.

Supriyo Bose headshot

3 Momentum Anomaly Stocks to Buy as Election Rally Fizzles

DOCS, PI and INOD are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.

Sanghamitra Saha headshot

Looking for Earnings Beat? Buy These 4 Top-Ranked Stocks

Top-ranked stocks Amazon.com (AMZN), Maplebear Inc. (CART), Exelixis (EXEL) and Doximity (DOCS) are likely to beat on the bottom line in their upcoming releases.

Zacks Equity Research

Surging Earnings Estimates Signal Upside for Doximity (DOCS) Stock

Doximity (DOCS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Equity Research

Are Medical Stocks Lagging CareDx (CDNA) This Year?

Here is how CareDx (CDNA) and Doximity (DOCS) have performed compared to their sector so far this year.

Zacks Equity Research

Doximity (DOCS) Tops Q2 Earnings and Revenue Estimates

Doximity (DOCS) delivered earnings and revenue surprises of 15.38% and 7.70%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

InnovAge Holding Corp. (INNV) Reports Q1 Loss, Tops Revenue Estimates

InnovAge (INNV) delivered earnings and revenue surprises of 0% and 0.88%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Doximity (DOCS) Outperforms Broader Market: What You Need to Know

Doximity (DOCS) closed at $41.88 in the latest trading session, marking a +1.11% move from the prior day.

Zacks Equity Research

Doximity (DOCS) Sees a More Significant Dip Than Broader Market: Some Facts to Know

In the most recent trading session, Doximity (DOCS) closed at $41.42, indicating a -1.76% shift from the previous trading day.

Zacks Equity Research

Is Janus Henderson Small Cap Growth Alpha ETF (JSML) a Strong ETF Right Now?

Smart Beta ETF report for JSML

Zacks Equity Research

Zacks Industry Outlook Highlights Elevance Health, Doximity and HealthEquity

Elevance Health, Doximity and HealthEquity are part of the Zacks Industry Outlook article.

Urmimala Biswas headshot

3 Medical Services Stocks to Buy to Navigate Industry Challenges

The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. ELV, DOCS and HQY are set to gain the most. Healthcare staffing shortages are leading to an increase in labor wages.

Zacks Equity Research

Are Medical Stocks Lagging Atea Pharmaceuticals (AVIR) This Year?

Here is how Atea Pharmaceuticals, Inc. (AVIR) and Doximity (DOCS) have performed compared to their sector so far this year.

Zacks Equity Research

Doximity (DOCS) Gains As Market Dips: What You Should Know

In the closing of the recent trading day, Doximity (DOCS) stood at $42.90, denoting a +0.87% change from the preceding trading day.

Zacks Equity Research

Doximity (DOCS) Increases Despite Market Slip: Here's What You Need to Know

Doximity (DOCS) reachead $40.88 at the closing of the latest trading day, reflecting a +0.62% change compared to its last close.

Zacks Equity Research

SOLV vs. DOCS: Which Stock Is the Better Value Option?

SOLV vs. DOCS: Which Stock Is the Better Value Option?

Zacks Equity Research

LTH vs. DOCS: Which Stock Is the Better Value Option?

LTH vs. DOCS: Which Stock Is the Better Value Option?